IMVT – Immunovant Inc
Immunovant, Inc.IMVT
$35.71Name : Immunovant, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $7,390,104,576.00
EPSttm : -2.56
Immunovant, Inc.
$35.71
1.59%$0.56
IMVT — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
21.54
Margin Of Safety %
Put/Call OI Ratio
0.09
EPS Next Q Diff
EPS Last/This Y
-0.07
EPS This/Next Y
0.09
Price
35.68
Target Price
48.12
Analyst Recom
1.47
Performance Q
-16.17
Upside
-192.8%
Beta
0.92
Ticker: IMVT
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-10-12 | IMVT | 29.48 | 0.08 | 0.02 | 32452 |
| 2026-10-13 | IMVT | 28.72 | 0.08 | 0.01 | 33761 |
| 2026-10-14 | IMVT | 27.92 | 0.08 | 0.03 | 34262 |
| 2026-10-15 | IMVT | 27.52 | 0.07 | 0.18 | 34929 |
| 2026-10-16 | IMVT | 26.74 | 0.07 | 0.12 | 35745 |
| 2026-10-19 | IMVT | 27.58 | 0.06 | 0.08 | 34025 |
| 2026-10-20 | IMVT | 28.59 | 0.06 | 0.01 | 35131 |
| 2026-10-21 | IMVT | 28.36 | 0.06 | 0.20 | 35752 |
| 2026-10-22 | IMVT | 29.11 | 0.06 | 0.17 | 36135 |
| 2026-10-23 | IMVT | 28.4 | 0.07 | 1.43 | 37056 |
| 2026-10-26 | IMVT | 28.17 | 0.09 | 0.26 | 38367 |
| 2026-10-27 | IMVT | 28.88 | 0.09 | 0.00 | 38601 |
| 2026-10-28 | IMVT | 29.45 | 0.09 | 0.43 | 38709 |
| 2026-10-29 | IMVT | 29.64 | 0.09 | 0.31 | 38827 |
| 2026-10-30 | IMVT | 29.14 | 0.09 | 0.11 | 38971 |
| 2026-11-02 | IMVT | 28.39 | 0.09 | 0.71 | 39322 |
| 2026-11-03 | IMVT | 29.01 | 0.09 | 0.35 | 39384 |
| 2026-11-04 | IMVT | 29.93 | 0.09 | 2.07 | 39528 |
| 2026-11-05 | IMVT | 28.41 | 0.09 | 0.20 | 39668 |
| 2026-11-06 | IMVT | 30.5 | 0.09 | 0.44 | 40087 |
| 2026-11-09 | IMVT | 35.15 | 0.09 | 0.03 | 40157 |
| 2026-11-10 | IMVT | 35.73 | 0.09 | 0.85 | 40516 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-10-12 | IMVT | 29.47 | -11.4 | - | -2.84 |
| 2026-10-13 | IMVT | 28.73 | -11.4 | - | -2.84 |
| 2026-10-14 | IMVT | 27.92 | -11.4 | - | -2.84 |
| 2026-10-15 | IMVT | 27.50 | -11.4 | - | -2.84 |
| 2026-10-16 | IMVT | 26.75 | -11.4 | - | -2.84 |
| 2026-10-19 | IMVT | 27.58 | -11.4 | - | -2.84 |
| 2026-10-20 | IMVT | 27.58 | -11.4 | - | -2.84 |
| 2026-10-21 | IMVT | 28.61 | -11.4 | - | -2.84 |
| 2026-10-22 | IMVT | 29.11 | -11.4 | - | -2.84 |
| 2026-10-23 | IMVT | 28.40 | -11.4 | - | -2.84 |
| 2026-10-26 | IMVT | 28.17 | -11.4 | - | -2.84 |
| 2026-10-27 | IMVT | 28.86 | -11.4 | - | -2.84 |
| 2026-10-28 | IMVT | 29.44 | -11.4 | - | -2.84 |
| 2026-10-29 | IMVT | 29.61 | -11.4 | - | -2.84 |
| 2026-10-30 | IMVT | 29.11 | -11.4 | - | -2.84 |
| 2026-11-02 | IMVT | 28.41 | -11.4 | - | -2.84 |
| 2026-11-03 | IMVT | 29.05 | -11.4 | - | -2.84 |
| 2026-11-04 | IMVT | 29.90 | -11.4 | - | -2.84 |
| 2026-11-05 | IMVT | 28.39 | -11.4 | - | -2.84 |
| 2026-11-06 | IMVT | 30.50 | -11.4 | - | -2.84 |
| 2026-11-09 | IMVT | 35.15 | -11.4 | - | -2.84 |
| 2026-11-10 | IMVT | 35.68 | -11.4 | - | -2.84 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-10-12 | IMVT | -0.32 | 0.46 | 20.53 |
| 2026-10-13 | IMVT | -0.32 | 0.46 | 20.53 |
| 2026-10-14 | IMVT | -0.32 | 0.46 | 20.53 |
| 2026-10-15 | IMVT | -0.32 | 0.46 | 20.53 |
| 2026-10-16 | IMVT | -0.32 | 0.46 | 20.53 |
| 2026-10-19 | IMVT | -0.32 | 0.43 | 20.53 |
| 2026-10-20 | IMVT | -0.32 | 0.43 | 20.53 |
| 2026-10-21 | IMVT | -0.32 | 0.43 | 20.53 |
| 2026-10-22 | IMVT | -0.32 | 0.43 | 20.53 |
| 2026-10-23 | IMVT | -0.32 | 0.43 | 20.53 |
| 2026-10-26 | IMVT | -0.30 | 0.53 | 20.53 |
| 2026-10-27 | IMVT | -0.30 | 0.53 | 21.54 |
| 2026-10-28 | IMVT | -0.30 | 0.53 | 21.54 |
| 2026-10-29 | IMVT | -0.30 | 0.53 | 21.54 |
| 2026-10-30 | IMVT | -0.30 | 0.53 | 21.54 |
| 2026-11-02 | IMVT | -0.30 | 0.52 | 21.54 |
| 2026-11-03 | IMVT | -0.30 | 0.52 | 21.54 |
| 2026-11-05 | IMVT | -0.30 | 0.52 | 21.54 |
| 2026-11-06 | IMVT | -0.30 | 0.52 | 21.54 |
| 2026-11-09 | IMVT | -0.30 | 0.75 | 21.54 |
| 2026-11-10 | IMVT | -0.30 | 0.75 | 21.54 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.72
Avg. EPS Est. Next Quarter
-0.67
Insider Transactions
-0.3
Institutional Transactions
0.75
Beta
0.92
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
10
Growth Score
19
Sentiment Score
83
Actual DrawDown %
21.7
Max Drawdown 5-Year %
-69.9
Target Price
48.12
P/E
Forward P/E
PEG
P/S
P/B
11.24
P/Free Cash Flow
EPS
-2.55
Average EPS Est. Cur. Y
-2.84
EPS Next Y. (Est.)
-2.75
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
1.15
Return on Equity vs Sector %
-100
Return on Equity vs Industry %
-84.1
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
◆
IMVT
Healthcare
$35.71
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
67.6
Range 1M
96%
Sup Dist
6.4%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
5.1%
EPS NY
-3.1%
52W%
58.3%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+34.8% upside
Upside
+34.8%
Quality
10
IMVT — P/E HistoricalBiotechnology
Immunovant, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 315
Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
IMVT
Latest News
—
Caricamento notizie per IMVT…
stock quote shares IMVT – Immunovant Inc Stock Price stock today
news today IMVT – Immunovant Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch IMVT – Immunovant Inc yahoo finance google finance
stock history IMVT – Immunovant Inc invest stock market
stock prices IMVT premarket after hours
ticker IMVT fair value insiders trading